These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 23133374)

  • 1. Design and evaluation of meningococcal vaccines through structure-based modification of host and pathogen molecules.
    Johnson S; Tan L; van der Veen S; Caesar J; Goicoechea De Jorge E; Harding RJ; Bai X; Exley RM; Ward PN; Ruivo N; Trivedi K; Cumber E; Jones R; Newham L; Staunton D; Ufret-Vincenty R; Borrow R; Pickering MC; Lea SM; Tang CM
    PLoS Pathog; 2012; 8(10):e1002981. PubMed ID: 23133374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonfunctional variant 3 factor H binding proteins as meningococcal vaccine candidates.
    van der Veen S; Johnson S; Jongerius I; Malik T; Genovese A; Santini L; Staunton D; Ufret-Vincenty RL; Pickering MC; Lea SM; Tang CM
    Infect Immun; 2014 Mar; 82(3):1157-63. PubMed ID: 24379280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H.
    Rossi R; Konar M; Beernink PT
    Infect Immun; 2016 Jun; 84(6):1735-1742. PubMed ID: 27021245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct binding and immunogenic properties of the gonococcal homologue of meningococcal factor h binding protein.
    Jongerius I; Lavender H; Tan L; Ruivo N; Exley RM; Caesar JJ; Lea SM; Johnson S; Tang CM
    PLoS Pathog; 2013; 9(8):e1003528. PubMed ID: 23935503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?
    Granoff DM; Ram S; Beernink PT
    Clin Vaccine Immunol; 2013 Aug; 20(8):1099-107. PubMed ID: 23740919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4CMenB vaccine induces elite cross-protective human antibodies that compete with human factor H for binding to meningococcal fHbp.
    Veggi D; Bianchi F; Santini L; Lo Surdo P; Chesterman CC; Pansegrau W; Bechi N; Huang Y; Masignani V; Pizza M; Rappuoli R; Bottomley MJ; Cozzi R; Maione D
    PLoS Pathog; 2020 Oct; 16(10):e1008882. PubMed ID: 33007046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human factor H (FH) impairs protective meningococcal anti-FHbp antibody responses and the antibodies enhance FH binding.
    Costa I; Pajon R; Granoff DM
    mBio; 2014 Aug; 5(5):e01625-14. PubMed ID: 25161192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Meningococcal Outer Membrane Vesicle Vaccine with Overexpressed Mutant FHbp Elicits Higher Protective Antibody Responses in Infant Rhesus Macaques than a Licensed Serogroup B Vaccine.
    Beernink PT; Vianzon V; Lewis LA; Moe GR; Granoff DM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31213564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site.
    Sands NA; Beernink PT
    PLoS Pathog; 2021 Jun; 17(6):e1009655. PubMed ID: 34125873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination.
    Beernink PT; Shaughnessy J; Braga EM; Liu Q; Rice PA; Ram S; Granoff DM
    J Immunol; 2011 Mar; 186(6):3606-14. PubMed ID: 21325619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.
    Beernink PT; Shaughnessy J; Pajon R; Braga EM; Ram S; Granoff DM
    PLoS Pathog; 2012; 8(5):e1002688. PubMed ID: 22589720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity in rhesus macaque complement factor H binding to meningococcal factor H binding protein (FHbp) informs selection of primates to assess immunogenicity of FHbp-based vaccines.
    Beernink PT; Shaughnessy J; Stefek H; Ram S; Granoff DM
    Clin Vaccine Immunol; 2014 Nov; 21(11):1505-11. PubMed ID: 25185576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal factor H binding protein fHbpd184 polymorphism influences clinical course of meningococcal meningitis.
    Piet JR; Brouwer MC; Exley R; van der Veen S; van de Beek D; van der Ende A
    PLoS One; 2012; 7(10):e47973. PubMed ID: 23110143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.
    Tzeng YL; Giuntini S; Berman Z; Sannigrahi S; Granoff DM; Stephens DS
    Infect Immun; 2020 Nov; 88(12):. PubMed ID: 32958529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to meningococcal factor H binding protein with overlapping epitopes and discordant functional activity.
    Giuntini S; Beernink PT; Reason DC; Granoff DM
    PLoS One; 2012; 7(3):e34272. PubMed ID: 22461909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.
    Pajon R; Beernink PT; Granoff DM
    Infect Immun; 2012 Aug; 80(8):2667-77. PubMed ID: 22615247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activity.
    Giuntini S; Pajon R; Ram S; Granoff DM
    Infect Immun; 2015 Apr; 83(4):1536-45. PubMed ID: 25644002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice.
    Rossi R; Granoff DM; Beernink PT
    Vaccine; 2013 Nov; 31(46):5451-7. PubMed ID: 24035433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of factor H-Binding protein sequence to the cross-reactivity of meningococcal native outer membrane vesicle vaccines with over-expressed fHbp variant group 1.
    Marini A; Rossi O; Aruta MG; Micoli F; Rondini S; Guadagnuolo S; Delany I; Henderson IR; Cunningham AF; Saul A; MacLennan CA; Koeberling O
    PLoS One; 2017; 12(7):e0181508. PubMed ID: 28742866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor H-dependent alternative pathway inhibition mediated by porin B contributes to virulence of Neisseria meningitidis.
    Lewis LA; Vu DM; Vasudhev S; Shaughnessy J; Granoff DM; Ram S
    mBio; 2013 Oct; 4(5):e00339-13. PubMed ID: 24129254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.